AAAAAA
Results:
1-22
|
Results: 22
Authors:
Morley, P
Whitfield, JF
Willick, GE
Citation: P. Morley et al., Parathyroid hormone: An anabolic treatment for osteoporosis, CUR PHARM D, 7(8), 2001, pp. 671-687
Authors:
Whitfield, JF
Citation: Jf. Whitfield, Leptin: brains and bones, EXPERT OP I, 10(9), 2001, pp. 1617-1622
Authors:
Whitfield, JF
Citation: Jf. Whitfield, Statins: new drugs for treating osteoporosis?, EXPERT OP I, 10(3), 2001, pp. 409-415
Authors:
Whitfield, JF
Isaacs, RJ
Chakravarthy, B
Maclean, S
Morley, P
Willick, G
Divieti, P
Bringhurst, FR
Citation: Jf. Whitfield et al., Stimulation of protein kinase C activity in cells expressing human parathyroid hormone receptors by C- and N-terminally truncated fragments of parathyroid hormone 1-34, J BONE MIN, 16(3), 2001, pp. 441-447
Authors:
Morley, P
Whitfield, JF
Willick, GE
Ross, V
MacLean, S
Barbier, JR
Isaacs, RJ
Andreassen, TT
Citation: P. Morley et al., The effect of monocyclic and bicyclic analogs of human parathyroid hormone(hPTH)-(1-31)NH2 on bone formation and mechanical strength in ovariectomized rats, CALCIF TIS, 68(2), 2001, pp. 95-101
Authors:
Barbier, JR
MacLean, S
Whitfield, JF
Morley, P
Willick, GE
Citation: Jr. Barbier et al., Structural requirements for conserved arginine of parathyroid hormone, BIOCHEM, 40(30), 2001, pp. 8955-8961
Authors:
Sung, WL
Chan, BS
Luk, CK
Zahab, DM
Willick, GE
Barbier, JR
Isaacs, R
Maclean, S
Ross, V
Morley, P
Whitfield, JF
Citation: Wl. Sung et al., High-yield expression of fully bioactive N-terminal parathyroid hormone analog in Escherichia coli, IUBMB LIFE, 49(2), 2000, pp. 131-135
Authors:
Whitfield, JF
Morley, P
Willick, GE
Citation: Jf. Whitfield et al., The parathyroid hormones: Bone-forming agents for treatment of osteoporosis, MEDSC W H, 5(5), 2000, pp. NIL_41-NIL_57
Authors:
Whitfield, JF
Morley, P
Willick, GE
Isaacs, RJ
MacLean, S
Ross, V
Barbier, JR
Divieti, P
Bringhurst, FR
Citation: Jf. Whitfield et al., Lactam formation increases receptor binding, adenylyl cyclase stimulation and bone growth stimulation by human parathyroid hormone (hPTH)(1-28)NH2, J BONE MIN, 15(5), 2000, pp. 964-970
Authors:
Whitfield, JF
Morley, P
Fraher, L
Hodsman, AB
Holdsworth, DW
Watson, PH
Willick, GE
Barbier, JR
Gulam, M
Isaacs, RJ
MacLean, S
Ross, V
Citation: Jf. Whitfield et al., The stimulation of vertebral and tibial bone growth by the parathyroid hormone fragments, hPTH-(1-31)NH2, [Leu(27)]cyclo(Glu(22)-Lys(26))hPTH-(1-31)NH2, and hPTH-(1-30)NH2, CALCIF TIS, 66(4), 2000, pp. 307-312
Authors:
Dal Pra, I
Whitfield, JF
Chiarini, A
Armato, U
Citation: I. Dal Pra et al., Increased activity of the protein kinase C-delta holoenzyme in the cytoplasmic particulate fraction precedes the activation of caspases in polyomavirus-transformed pyF111 rat fibroblasts exposed to calphostin C or topoisomerase-II inhibitors, EXP CELL RE, 255(2), 2000, pp. 171-183
Authors:
Barbier, JR
MacLean, S
Morley, P
Whitfield, JF
Willick, GE
Citation: Jr. Barbier et al., Structure and activities of constrained analogues of human parathyroid hormone and parathyroid hormone-related peptide: Implications for receptor-activating conformations of the hormones, BIOCHEM, 39(47), 2000, pp. 14522-14530
Authors:
Whitfield, JF
Morley, P
Willick, GE
Citation: Jf. Whitfield et al., The bone-building action of the parathyroid hormone - Implications for thetreatment of osteoporosis, DRUG AGING, 15(2), 1999, pp. 117-129
Authors:
Morley, P
Whitfield, JF
Willick, GE
Citation: P. Morley et al., Design and applications of parathyroid hormone analogues, CURR MED CH, 6(11), 1999, pp. 1095-1106
Authors:
Whitfield, JF
Isaacs, R
Maclean, S
Morley, P
Barbier, JR
Willick, GE
Citation: Jf. Whitfield et al., Stimulation of membrane-associated protein kinase-C activity in spleen lymphocytes by hPTH-(1-31)NH2, its lactam derivative, [Leu(27)]-cyclo(Glu(22)-Lys(26))-hPTH-(1-31)NH2, and hPTH-(1-30)NH2, CELL SIGNAL, 11(3), 1999, pp. 159-164
Authors:
Morley, P
Whitfield, JF
Willick, GE
Ross, V
MacLean, S
Isaacs, RJ
Mendoza, E
Barbier, JR
Citation: P. Morley et al., Prolonged low-dose infusion of human parathyroid hormone does not increasefemoral cancellous bone volume in ovariectomized rats, EUR J ENDOC, 141(1), 1999, pp. 70-74
Authors:
Whitfield, JF
Morley, P
Willick, GE
MacLean, S
Ross, V
Barbier, JR
Isaacs, RJ
Citation: Jf. Whitfield et al., Stimulation of femoral trabecular bone growth in ovariectomized rats by human parathyroid hormone (hPTH)-(1-30)NH2, CALCIF TIS, 65(2), 1999, pp. 143-147
Authors:
Fraher, LJ
Avram, R
Watson, PH
Hendy, GN
Henderson, JE
Chong, KL
Goltzman, D
Morley, P
Willick, GE
Whitfield, JF
Hodsman, AB
Citation: Lj. Fraher et al., Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans, J CLIN END, 84(8), 1999, pp. 2739-2743
Authors:
Dal Pra, I
Whitfield, JF
Chiarini, A
Armato, U
Citation: I. Dal Pra et al., Changes in nuclear protein kinase C-delta holoenzyme, its catalytic fragments, and its activity in polyomavirus-transformed pyF111 rat fibroblasts while proliferating and following exposure to apoptogenic topoisomerase-II inhibitors, EXP CELL RE, 249(1), 1999, pp. 147-160
Authors:
Friedman, PA
Gesek, FA
Morley, P
Whitfield, JF
Willick, GE
Citation: Pa. Friedman et al., Cell-specific signaling and structure-activity relations of parathyroid hormone analogs in mouse kidney cells, ENDOCRINOL, 140(1), 1999, pp. 301-309
Authors:
Belinsky, GS
Morley, P
Whitfield, JF
Tashjian, AH
Citation: Gs. Belinsky et al., Ca2+ and extracellular acidification rate responses to parathyroid hormonefragments in rat ROS 17/2 and human SaOS-2 cells, BIOC BIOP R, 266(2), 1999, pp. 448-453
Authors:
Krsmanovic, V
Biquard, JM
Sikorska-Walker, M
Cosic, I
Desgranges, C
Trabaud, MA
Whitfield, JF
Durkin, JP
Achour, A
Hearn, MTW
Citation: V. Krsmanovic et al., Investigations into the crossreactivity of rabbit antibodies raised against nonhomologous pairs of synthetic peptides derived from HIV-1 gp120 proteins, J PEPT RES, 52(5), 1998, pp. 410-420
Risultati:
1-22
|